DE59814211D1 - Verfahren zur reinigung von faktor viii/vwf-komplex mittels kationenaustauscherchromatographie - Google Patents

Verfahren zur reinigung von faktor viii/vwf-komplex mittels kationenaustauscherchromatographie

Info

Publication number
DE59814211D1
DE59814211D1 DE59814211T DE59814211T DE59814211D1 DE 59814211 D1 DE59814211 D1 DE 59814211D1 DE 59814211 T DE59814211 T DE 59814211T DE 59814211 T DE59814211 T DE 59814211T DE 59814211 D1 DE59814211 D1 DE 59814211D1
Authority
DE
Germany
Prior art keywords
cation exchange
exchange chromatography
factor viii
vwf complex
cleaning factor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE59814211T
Other languages
German (de)
English (en)
Inventor
Artur Mitterer
Bernhard Fischer
Oeyvind L Schoenberger
Kathrin Thomas-Urban
Friedrich Dorner
Johann Eibl
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Baxter AG
Original Assignee
Baxter AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=3487946&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE59814211(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Baxter AG filed Critical Baxter AG
Application granted granted Critical
Publication of DE59814211D1 publication Critical patent/DE59814211D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/37—Factors VIII
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE59814211T 1997-02-27 1998-02-27 Verfahren zur reinigung von faktor viii/vwf-komplex mittels kationenaustauscherchromatographie Expired - Lifetime DE59814211D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT0033897A AT406373B (de) 1997-02-27 1997-02-27 Verfahren zur reinigung von faktor viii/vwf-komplex mittels kationenaustauscherchromatographie
PCT/AT1998/000043 WO1998038220A1 (de) 1997-02-27 1998-02-27 Verfahren zur reinigung von faktor viii/vwf-komplex mittels kationenaustauscherchromatographie

Publications (1)

Publication Number Publication Date
DE59814211D1 true DE59814211D1 (de) 2008-05-21

Family

ID=3487946

Family Applications (1)

Application Number Title Priority Date Filing Date
DE59814211T Expired - Lifetime DE59814211D1 (de) 1997-02-27 1998-02-27 Verfahren zur reinigung von faktor viii/vwf-komplex mittels kationenaustauscherchromatographie

Country Status (11)

Country Link
US (3) US6831159B1 (cg-RX-API-DMAC7.html)
EP (1) EP0971958B2 (cg-RX-API-DMAC7.html)
JP (1) JP4250771B2 (cg-RX-API-DMAC7.html)
AR (2) AR010121A1 (cg-RX-API-DMAC7.html)
AT (2) AT406373B (cg-RX-API-DMAC7.html)
AU (1) AU744919B2 (cg-RX-API-DMAC7.html)
CA (1) CA2282841C (cg-RX-API-DMAC7.html)
DE (1) DE59814211D1 (cg-RX-API-DMAC7.html)
ES (1) ES2306471T5 (cg-RX-API-DMAC7.html)
NO (2) NO324902B1 (cg-RX-API-DMAC7.html)
WO (1) WO1998038220A1 (cg-RX-API-DMAC7.html)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT406373B (de) 1997-02-27 2000-04-25 Immuno Ag Verfahren zur reinigung von faktor viii/vwf-komplex mittels kationenaustauscherchromatographie
EP1593388A1 (en) * 2004-05-05 2005-11-09 ZLB Behring GmbH Therapeutic plasma protein-concentrates containing von willebrand factor as high molecular weight multimers
US11197916B2 (en) 2007-12-28 2021-12-14 Takeda Pharmaceutical Company Limited Lyophilized recombinant VWF formulations
ES2298096B1 (es) 2008-01-08 2009-01-01 Grifols, S.A. Procedimiento para la obtencion de un concentrado de factor von willebrand o del complejo de factor viii/factor von willebrand y utilizacionde los mismos.
EP2349314B1 (en) 2008-10-21 2013-02-27 Baxter International Inc. Lyophilized recombinant vwf formulations
MX2012002129A (es) * 2009-08-20 2012-06-08 Baxter Int Purificacion del factor de von willebrand (vwf) para remocion incrementada de virus envueltos sin lipido.
RU2579977C2 (ru) 2009-11-13 2016-04-10 Грифольс Терапьютикс Инк. СОДЕРЖАЩИЕ ФАКТОР ФОН ВИЛЛЕБРАНДА (vWF) ПРЕПАРАТЫ И СПОСОБЫ, НАБОРЫ И ПРИМЕНЕНИЯ, СВЯЗАННЫЕ С НИМИ
WO2012015908A2 (en) 2010-07-30 2012-02-02 Millipore Corporation Chromatography media and method
EP2652491B1 (en) 2010-12-15 2017-11-29 Baxalta GmbH Eluate collection using conductivity gradient
CN103732244A (zh) * 2011-06-10 2014-04-16 巴克斯特国际公司 通过施用重组vwf治疗凝血疾病
AU2012290004B2 (en) 2011-08-02 2014-11-27 Takeda Pharmaceutical Company Limited Systems and methods to increase protein yield from recombinant manufacturing processes
US8946460B2 (en) 2012-06-15 2015-02-03 Commonwealth Scientific And Industrial Research Organisation Process for producing polyunsaturated fatty acids in an esterified form
WO2014083510A1 (en) * 2012-11-30 2014-06-05 Centre For Bioseparation Technology - Vit Monolith-based pseudo-bioaffinity purification methods for factor viii and applications thereof
ES2693380T3 (es) 2013-11-08 2018-12-11 Csl Limited Nuevo método para concentrar el factor de von Willebrand o complejos de este
WO2015196250A1 (en) 2014-06-27 2015-12-30 Commonwealth Scientific And Industrial Research Organisation Lipid comprising docosapentaenoic acid
KR102386838B1 (ko) 2013-12-18 2022-04-15 커먼웰쓰 사이언티픽 앤 인더스트리알 리서치 오거니제이션 장쇄 다중불포화 지방산을 포함하는 지질
EP3188816B1 (en) 2014-09-02 2021-06-09 EMD Millipore Corporation Chromatography media comprising discrete porous bundles of nanofibrils
US20170298091A1 (en) 2014-12-08 2017-10-19 Emd Millipore Corporation Mixed Bed Ion Exchange Adsorber
FI3648788T5 (fi) 2017-07-07 2024-09-09 Takeda Pharmaceuticals Co Maha-suolikanavan verenvuodon hoito vaikeaa von willebrandin tautia sairastavilla potilailla antamalla rekombinanttia vwf:ää
JP7326246B2 (ja) 2017-07-07 2023-08-15 武田薬品工業株式会社 待機手術を受ける、重度のフォンヴィレブランド病を患う患者の、組換えvwfの投与による治療法
EA202192140A1 (ru) 2019-02-01 2021-12-15 Такеда Фармасьютикал Компани Лимитед СПОСОБЫ ПРОФИЛАКТИЧЕСКОГО ЛЕЧЕНИЯ РЕКОМБИНАНТНЫМ ФВ (рФВ)
CN114106145B (zh) * 2021-10-22 2023-09-01 山东泰邦生物制品有限公司 一种血源人凝血因子ⅷ/血管性血友病因子复合物生产工艺

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4540573A (en) 1983-07-14 1985-09-10 New York Blood Center, Inc. Undenatured virus-free biologically active protein derivatives
GB8403473D0 (en) * 1984-02-09 1984-03-14 Special Trustees For St Thomas Purification of factor viii
US5200510A (en) * 1987-06-16 1993-04-06 Zymogenetics, Inc. Method for purifying factor viii:c, von willebrand factor and complexes thereof
FR2651437A1 (fr) * 1989-09-05 1991-03-08 Lille Transfusion Sanguine Procede de preparation de concentre du complexe facteur viii-facteur von willebrand de la coagulation sanguine a partir de plasma total.
NZ237244A (en) 1990-03-02 1992-10-28 Bio Technology General Corp Cloning and production of human von willebrand factor analogues and compositions thereof
FR2686899B1 (fr) * 1992-01-31 1995-09-01 Rhone Poulenc Rorer Sa Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant.
IT1256622B (it) * 1992-12-04 1995-12-12 Sclavo Spa Processo per l'estrazione del complesso fattore viii-fattore von willebrand (fviii:c-fvw) da plasma umano totale.
CA2159044A1 (en) 1994-09-26 1996-03-27 Falko-Guenter Falkner Method of quantitating nucleic acids
AT401270B (de) 1994-09-26 1996-07-25 Immuno Ag Verfahren zur quantifizierung von genomischer dna
DE4435392B4 (de) * 1994-10-04 2008-02-07 Immuno Ag Verfahren zur Trennung von vWF in hochmolekularen vWF und niedermolekularen vWF
DE4435485C1 (de) 1994-10-04 1996-03-21 Immuno Ag Verfahren zur Gewinnung von hochreinem von Willebrand-Faktor
AT403764B (de) * 1996-03-15 1998-05-25 Immuno Ag Stabiler faktor viii/vwf-komplex
CA2251558C (en) 1996-04-12 2005-11-22 Immuno Aktiengesellschaft Highly purified factor viii complex
AT403765B (de) 1996-04-12 1998-05-25 Immuno Ag Verfahren zur herstellung einer präparation enthaltend einen hochgereinigten komplex
AT405403B (de) 1997-02-27 1999-08-25 Immuno Ag Reinigung von von willebrand-faktor durch kationenaustauscherchromatographie
AT406373B (de) 1997-02-27 2000-04-25 Immuno Ag Verfahren zur reinigung von faktor viii/vwf-komplex mittels kationenaustauscherchromatographie

Also Published As

Publication number Publication date
ES2306471T3 (es) 2008-11-01
NO994137L (no) 1999-08-26
US20020058625A1 (en) 2002-05-16
WO1998038220A1 (de) 1998-09-03
AR059902A2 (es) 2008-05-07
AU6080698A (en) 1998-09-18
AT406373B (de) 2000-04-25
US6831159B1 (en) 2004-12-14
EP0971958A1 (de) 2000-01-19
US7648958B2 (en) 2010-01-19
EP0971958B2 (de) 2012-02-08
CA2282841C (en) 2008-12-02
EP0971958B1 (de) 2008-04-09
NO20071357L (no) 1999-08-26
NO994137D0 (no) 1999-08-26
AU744919B2 (en) 2002-03-07
ATA33897A (de) 1999-09-15
ES2306471T5 (es) 2012-06-07
NO326257B1 (no) 2008-10-27
ATE391728T1 (de) 2008-04-15
AR010121A1 (es) 2000-05-17
JP4250771B2 (ja) 2009-04-08
JP2001517212A (ja) 2001-10-02
US20050239171A1 (en) 2005-10-27
CA2282841A1 (en) 1998-09-03
NO324902B1 (no) 2007-12-27
US6953837B2 (en) 2005-10-11

Similar Documents

Publication Publication Date Title
ATA33897A (de) Verfahren zur reinigung von faktor viii/vwf-komplex mittels kationenaustauscherchromatographie
DE59809522D1 (de) Verfahren zur Steuerung von Koordinatenmessgeräten nach Solldaten
DE69841822D1 (de) Verfahren zum Herstellen von Faserbündeln
DE69522868D1 (de) Verfahren zum Herstellen von Äthylen
DE69634732D1 (de) Verfahren zur reinigung von bürsten
DE69502053D1 (de) Verfahren zur Reinigung der Akrylsäure
ATE307824T1 (de) Verfahren für die reinigung von interferon- proteinen mittels kationen- austauschchromatographie
EP0791095A4 (en) Method of cleaning carpets
DE50207548D1 (de) Verfahren zum Herstellen von schalenförmigen Verzehrgütern
DE59813968D1 (de) VERFAHREN ZUR GEWINNUNG VON HOCHREINEM vWF ODER FACTOR VIII/vWF-KOMPLEX
DE69935929D1 (de) Verfahren zur reinigung von blutbestandteilen
DE69502137D1 (de) Verfahren zur Methathesis von Olefinen
DE69502997D1 (de) Verfahren zum Herstellen von Bürsten
DE69630559D1 (de) Verfahren zum Beschichten von Flachglas
DE69406275D1 (de) Kontinuierliches verfahren zur reinigung von perfluorchemischen zusammensetzungen
DE69701109D1 (de) Verfahren zur Reinigung organometallischer Verbindungen
DE59406706D1 (de) Verfahren zum Reinigen von Hohlfasern
DE69709695T8 (de) Verfahren zur seitenzusammensetzung
DE69529854D1 (de) Verfahren zum Reinigen von Melkbechern
DE59711732D1 (de) Reinigung von faktor viii-komplex durch immunaffinitätschromatographie
DE69324728D1 (de) Verfahren zur Reinigung von Phenol
DE69807148D1 (de) Verfahren zur Hydroformylierung von Olefininen
DE69516317D1 (de) Verfahren zur Reinigung von Fullerenen
DE59503156D1 (de) Verfahren zur Aufarbeitung von komplexen Aminhydrofluoriden
DE69807371D1 (de) Verfahren zur Reinigung von Flüssigkristallen

Legal Events

Date Code Title Description
8363 Opposition against the patent
R082 Change of representative

Ref document number: 971958

Country of ref document: EP

Representative=s name: BIRD & BIRD LLP, DE